评估肝胆胰外科手术质量:全国性标杆管理
该研究基于荷兰两项全国性肝胆胰审计(DHBA和DPCA)2014至2021年数据,采用样本量计算确定以两年期(2020-2021)年最小20例切除术的现行容量要求为基准的统计离群中心识别阈值,覆盖死亡率、失败救援(FTR)、主要并发症率和教科书/理想结局(TO)。结论认为当前事件率和每院最低容量要求过低,无法检测死亡率与FTR有意义的院间差异,主要并发症率和TO更适合用于标杆管理。
要点
- 死亡率与FTR的现行事件率和最低容量要求过低,无法检测有意义的院间差异。
- 主要并发症率和TO是更适合用于标杆管理的候选指标。
- 医院容量越高,检测离群中心的阈值越低。
核心结论
- 当前事件率和每院最低容量要求过低,无法检测死亡率与FTR有意义的院间差异;主要并发症率和TO更适合用于标杆管理。
研究设计与样本
- 基于人群的研究,使用荷兰两项全国性肝胆胰审计(DHBA和DPCA)2014至2021年数据,共纳入10963例肝切除和7365例胰腺切除患者。
主要发现
- 小范围肝切除、大范围肝切除、胰十二指肠切除和远端胰腺切除的死亡率标杆分别为0.6%(范围0-3.2%)、3.3%(范围0-16.7%)、2.7%(范围0-7.0%)和0.6%(范围0-4.2%)。
- 小范围肝切除、大范围肝切除、胰十二指肠切除和远端胰腺切除的FTR率分别为5.4%(范围0-33.3%)、14.2%(范围0-100%)、7.5%(范围1.6%-28.5%)和3.1%(范围0-14.9%)。
- 小范围肝切除、大范围肝切除、胰十二指肠切除和远端胰腺切除的主要并发症率分别为9.8%(范围0-20.5%)、28.1%(范围0-47.1%)、36%(范围15.8%-58.3%)和22.3%(范围5.2%-46.1%)。
- 小范围肝切除、大范围肝切除、胰十二指肠切除和远端胰腺切除的TO率分别为73.6%(范围61.3%-94.4%)、54.1%(范围35.3-100)、46.8%(范围25.3%-59.4%)和63.3%(范围30.7%-84.6%)。
- 提示显著离群中心的死亡率阈值:小范围肝切除8.6%、大范围肝切除15.4%、胰十二指肠切除14.2%、远端胰腺切除8.6%;FTR阈值分别为17.9%、31.6%、22.9%和15.0%;主要并发症率阈值分别为26.1%、49.7%、57.9%和52.9%;TO较低阈值分别为52.5%、32.5%、25.8%和41.4%。
临床怎么用
- 作者认为主要并发症率和TO是更适合用于标杆管理的候选指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical auditing is a powerful tool to evaluate and improve healthcare. Deviations from the expected quality of care are identified by benchmarking the results of individual hospitals using national averages. This study aimed to evaluate the use of quality indicators for benchmarking hepato-pancreato-biliary (HPB) surgery and when outlier hospitals could be identified. METHODS: A population-based study used data from two nationwide Dutch HPB audits (DHBA and DPCA) from 2014 to 2021. Sample size calculations determined the threshold (in percentage points) to identify centres as statistical outliers, based on current volume requirements (annual minimum of 20 resections) on a two-year period (2020-2021), covering mortality rate, failure to rescue (FTR), major morbidity rate and textbook/ideal outcome (TO) for minor liver resection (LR), major LR, pancreaticoduodenectomy (PD) and distal pancreatectomy (DP). RESULTS: In total, 10 963 and 7365 patients who underwent liver and pancreatic resection respectively were included. Benchmark and corresponding range of mortality rates were 0.6% (0 -3.2%) and 3.3% (0-16.7%) for minor and major LR, and 2.7% (0-7.0%) and 0.6% (0-4.2%) for PD and DP respectively. FTR rates were 5.4% (0-33.3%), 14.2% (0-100%), 7.5% (1.6%-28.5%) and 3.1% (0-14.9%). For major morbidity rate, corresponding rates were 9.8% (0-20.5%), 28.1% (0-47.1%), 36% (15.8%-58.3%) and 22.3% (5.2%-46.1%). For TO, corresponding rates were 73.6% (61.3%-94.4%), 54.1% (35.3-100), 46.8% (25.3%-59.4%) and 63.3% (30.7%-84.6%). Mortality rate thresholds indicating a significant outlier were 8.6% and 15.4% for minor and major LR and 14.2% and 8.6% for PD and DP. For FTR, these thresholds were 17.9%, 31.6%, 22.9% and 15.0%. For major morbidity rate, these thresholds were 26.1%, 49.7%, 57.9% and 52.9% respectively. For TO, lower thresholds were 52.5%, 32.5%, 25.8% and 41.4% respectively. Higher hospital volumes decrease thresholds to detect outliers. CONCLUSION: Current event rates and minimum volume requirements per hospital are too low to detect any meaningful between hospital differences in mortality rate and FTR. Major morbidity rate and TO are better candidates to use for benchmarking.
引用
- de Graaff MR, Hendriks TE, Wouters M, et al. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking. Br J Surg. 2024. PMID: 38747683. doi:10.1093/bjs/znae119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。